Many factors are found to express abnormally in AD patients or animals, such as tumor necrosis factor (TNF)-α8, brain-derived neurotrophic factor (BDNF)9, homocysteine10, and C-reactive protein (CRP)11. BDNF and CRP are both widely studied factors in AD development. Lower BDNF levels were found in AD patients, higher BDNF serum levels were correlated with slower cognitive decline in AD patients12. For CRP, lower levels of CRP were observed in AD patients than the healthy13. Besides, among the factors, the human complement factor H (CFH), which is considered to play an important role in the stimulation of pro-inflammatory responses, has been noticed in AD development14,15. Animal researches showed CFH was down-regulated in AD models16; however in clinical studies, the results are still controversial17. Some researches indicate CFH is abnormally expressed in AD, however others showed no significant difference was found15,18. Similar dispute is also found in levels of CRP. Despite the findings that CRP was decreased in AD patients, a recent study provided opposite results19,20.